Search
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 1 of 1 items.
EVUSHELD (tixagevimab and cilgavimab for injection) - Risk of Prophylaxis or Treatment Failure due to Antiviral Resistance
AlertHealth professional risk communication | 2022-10-26